-
-
-
-
-
-
-
Eli Lilly to acquire AtaiBeckley for up to $3.8B
-
-
-
-
-
-
-
Peptide Wellness Market Could Near $300 Billion as Consumer Demand Accelerates
-
-
-
-
-
-
-
Lilly reports first-quarter 2026 financial results, raises full year guidance, and highlights momentum of new medicines
-
-
-
-
-
-
-
Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies
-
-
-
-
-
-
-
Barclays launches U.S. biopharma coverage with four preferred picks
-
-
-
-
-
-
-
Bernstein on Eli Lilly (LLY): 'Raising expectations into 2026'
-
-
-
-
-
-
-
Analysts expect this mega-cap pharma stock to outperform this year
-
1,216,217 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

